Stroke Manual Flashcards
What are the three components of stroke that are taken into account with the Oxfordshire Classification of Stroke?
- Hemianopia
- Higher cortical functions
- Unilateral motor or sensory deficit
Give the Oxfordshire Classification of Stroke: 1. Hypertensive 66M presenting with homonymous hemianopia with ipsilateral ataxia?2. 72F with left sided weakness and dressing apraxia? Both with hypodensities on CT
- POCI
2. PACI
What are the 5 different TOAST classifications?
- Large artery atherosclerosis 2. Cardioembolism 3. Small artery occlusion 4. Other determined causes 5. Undetermined cause (2 causes found or no cause found despite work-up)
What is the classification for a patient who presents with right sided weakness that on workup shows a >50% stenosis of the left ICA?
LAA
Give the ABCD score of the patient: 50 years oldBP of 140/90 Presented with broca's aphasia Lasting for 10 minutes No diabetes
0+0+1+1+1 = 3
No admission needed: 2 day stroke risk is 1%
Age ≥60 years 1 Blood pressure elevation (systolic >140 mmHg and/or diastolic ≥90 mmHg) 1 Clinical features Unilateral weakness 2 Speech disturbance without weakness 1 Duration of symptoms ≥60 minutes 2 10-59 minutes 1 Diabetes mellitus 1
Give the ABCD score of the patient:70 years oldBP of 141/90Presented with right sided plegiaLasting for 2 hoursWith DM
1+1+2+2+1= 7
ADMIT the patient
Score 1-3 (low)2 day risk = 1.0%7 day risk = 1.2%
Score 4-5 (moderate)2 day risk = 4.1%7 day risk = 5.9%
Score 6–7 (high)2 day risk = 8.1%7 day risk = 11.7%
How long should one wait prior to the starting of anti-platelet in a patient who underwent thrombolysis?
24 hours
What percentage of obstruction in the carotid UTZ necessitates referral to a neurosurgeon?
70%
Which among the 2 big ASA trials compared aspirin against ASA only, Heparin, ASA + Heparin and Placebo?
International Stroke Trial
The CAST (Chinese acute stroke trial) only compared against placebo VS ASA 160mg)
What antiplatelet was proved to be non-inferior to aspirin? (CAIST trial)
Cilostazol in Acute Ischemic Stroke
In the CAIST trial what was the NIHSS of the patient included? How about in the CHANCE trial?
CAIST: <15
CHANCE: 3 or less
Match the following neuroprotection agents with their trials:
- Cerebrolysin
- Citicoline
- NeuroAID
A. CHIMES
B. ICTUS
C. CASTA
1C
2B
3A
In what subgroups is citicoline shown to have some possible benefit according to the ICTUS trial?
> 70 years old
<14 NIHSS
Patients NOT treated with rtPA
What laboratory values of the following would discourage the use of rTPA? PLT PT INR BP CBG
PLT <100,000 PT >15sa PTT>40s INR >1.7 BP >=185/110 CBG <50 >400
What is the period after the following events during which thrombolysis is discouraged?
- Head trauma
- CVD infarct
- ICH
- MI
- Major surgery or serious trauma
- Arterial puncture
- AVM or aneurysm
- Head trauma 3 months
- CVD infarct 3 months
- ICH FOREVER
- MI 3 months
- Major surgery or serious trauma 14 days
- Arterial puncture 7 days
- AVM or aneurysm FOREVER
How should BP be monitored during thrombolysis?
Q15 first 2 hours
Q30 next 6 hours
Q1 for 16 hours
What are the 4 relative exclusion criteria to thrombolyse within the 3-4.5 hour criteria? (This is based on the old ischemic stroke guidelines NOT the 2018 AHA)
- DM and Ischemic stroke
- NIHSS more than 25
- Oral anticoagulants REGARDLESS OF INR
- Older than 80
In the National Institute of Neurological Disorders and Stroke t-PA trial 1. what is the primary outcome result in terms of disability at 3 months2.what is the primary outcome result in terms of mortality at 3 months3. what is the rate of sICH
- 30% more likely to have minimal or no disability (defined as MRS 0-1, NIHSS < or equal to 1, 95-100 on the Barthel index) at 3 months
- NO difference
- 6.4%
What dosage was used in the J-ACT trial using alteplase for thrombolysis?
0.6mg per kg
Which ECASS (European Australasian Cooperative Acute Stroke Study) trial showed improved outcomes with thrombolysed patients?
ECASS 3. The first two used up to 6 hours window period for giving of rtpa while the 3rd used 4.5 hours
In IST 3, what was the golden period used? Did it improve the Oxford Handicap Score (OHS) of 0–2 at 6 months of the patients?
<6 hours. BUT not enough power to say that there is enough evidence to thrombolyse at 4.5-6 hours
Yes it did!
What factor of the STATE criteria does this man meet?NIHSS 21 with plegic right
12 hours post ictus
ASPECTS 3
Previously working as a secretary
Score >20 if dominant lobe >15 if non dominant Timing <48 hours Age <60 years Territory >50% MCA territory Expectation reasonable 5/5!
According to the Antiplatelet Trialists Collaboration taking ASA can have a _____% odds reduction for the composite outcome of MI, stroke or vascular death.
23
Identify which antiplatelet is studied in the following:
- CATS
- CAPRIE
- CHARISMA
- SPS 3
- CSPS
- TOSS 1, TOSS 2
- ESPS 1, ESPS2
- ESPRIT
- PROFESS
- TACIP
- WARSS, WASID
- TAPIRSS
- TASS
- CATS: Ticlodipine VS placebo– old study!! 1989
- CAPRIE: Clopidogrel vs ASA
- CHARISMA: Clopidogrel + ASA VS ASA alone for vascular events
- SPS 3: Clopidogrel + Aspirin VS ASA for recent lacunar strokes
- CSPS Cilostazol vs Placebo Cilostazol superior CSPS 2: Cilostazol VS Aspirin, non inferiority study– less hemrrhage with Cilostazol
- TOSS 1: Cilostazol + ASA VS ASA alone for IC stenosis
TOSS 2: Cilostazol + ASA VS Cilostazol + Clopidogrel for IC stenosis - ESPS 1: ASA+ Dipyridamole VS ASA + Placebo
ESPS 2: ASA vs Dipyridamole VS ASA+ Dipyridamole VS Placebo - ESPRIT: ASA+ Dipyridamole VS ASA + Placebo
- PROFESS: ASA-Dipyridamole VS Clopidogrel– same recurrence of stroke but more bleeding with ASA+D
- TACIP: Triflusal VS ASA– less hemorrhage with triflusal
- WARSS: Warfarin vs Aspirin for secondary prevention, neutral
WASID: Warfarin vs Aspirin for large artery stenosis, neutral - TAPIRSS: Triflusal vs ASA – less hemorrhage with triflusal, neutral
- TASS: Ticlodipine vs ASA– ticlodipine superior
What is the CHA2DS2VASc score of the this patient?
75 F
With CHF FC3
Hypertensive with DM
Suffered from sudden right sided weakness
With aortic plaque on x-ray
1+2+1+1+2+1+1= 9 15.2% annual risk of stroke MORE THAN 2 score is considered high risk (2.2% risk of stroke) Congestive heart failure / LV dysfunction (1 point) Hypertension (1 point) Diabetes Mellitus (1 point) History of stroke TIA or thromboembolism (2 points) Vascular disese (history of MI, PVD or aortic atherosclerosis) (1 point) Age 65-74 years old (1 point) >= 75 years old (2 points) Sex: Female (1 point)
Threshold more than or equal to 2 score
What is the CHA2DS2VASc score of the this patient?
65 F
NO CHF
Hypertensive with DM
Amputated right leg from acute limb ischemia
1+1+0+1+1+1 = 5
6.0% annual risk of stroke
What is the HAS BLED score of this patient? Hypertensive Normal crea and AST ALT No history of stroke With anemia Stable INR's 70 on Aspirin and drinks alcohol daily
1+0+0+1+0+1+1= 4 8.7 major bleeds per 100 patient years
H Hypertension: (uncontrolled, >160 mmHg systolic)
A Abnormal renal function: Dialysis, transplant, Cr>2.26 mg/dL or >200 µmol/L
Abnormal liver function: Cirrhosis or Bilirubin >2x Normal or AST/ALT/AP >3x Normal
S Stroke: Prior history of stroke
B Bleeding: Prior Major Bleeding or Predisposition to Bleeding
L Labile INR: (Unstable/high INR), Time in Therapeutic Range
E Elderly 65 years old
D Prior Alcohol or Drug Usage History (≥ 8 drinks/week) Medication Usage Predisposing to Bleeding: (Antiplatelet agents, NSAIDs)
MORE THAN OR EQUAL TO 3 IS HIGH RISK!
Match the study with the drug:
- Dabigatran
- Apixaban
- Rivaroxaban
A. RELY AF
B. ARISTOTLE
C. ROCKET AF
1A
2B
3C
Which NOAC
- has the lowest half life?
- canNOT be given by NGT
- given OD 20mg tab
- superior to warfarin in ischemic stroke
- superior to warfarin in stroke and sytemic embolism
- superior to warfarin in terms of major bleeding (2)
- has the lowest half life: Rivaroxaban
- canNOT be given by NGT: Dabigatran
- given OD 20mg tab: Rivaroxaban
- superior to warfarin in ischemic stroke: Dabigatran 150BID
- superior to warfarin in stroke and sytemic embolism: Dabigatran and Apixaban
- superior to warfarin in terms of major bleeding: Dabigatran 110 BID and Apixaban
What HAS BLED score is a relative contraindication to warfarin therapy because it indicates a high risk of bleeding?
> =3
When switching from warfarin to NOAC what is the ideal INR (less than what) value before the shift happens?
<2.5
What ICH score gives a 100% mortality at 30 days?
5 -6 GCS score 3–4 2; 5–12 1; 13–15 0 ICH volume, cm3 ≥30 1; <30 0IVH Yes 1; No 0 Infratentorial origin of ICH Yes 1; No 0 Age, y ≥80 1; <80 0
What is the ICH score? GCS 8 Size 31cc NO IVH left parietal 81 years old
1+1+0+0+1=3: 72% mortality in 30 days GCS score 3–4 2; 5–12 1; 13–15 0 ICH volume, cm3 ≥30 1; <30 0 IVH Yes 1; No 0 Infratentorial origin of ICH Yes 1; No 0 Age, y ≥80 1; <80 0
What is the ICH score? GCS 3 8 cc With IVH Cerebellar 79 years old
2+0+1+1+0=4: 87% mortality in 30 days GCS score 3–4 2; 5–12 1; 13–15 0 ICH volume, cm3 ≥30 1; <30 0 IVH Yes 1; No 0 Infratentorial origin of ICH Yes 1; No 0 Age, y ≥80 1; <80 0
What is the sensitivity of scan 6 days after SAH headache?
57-85%
What HH or WFNS score?
- GCS 13 with right hemiparesis?
- GCS 7 with left plegia
- GCS 4, moribund
- GCS 14 no motor deficit, disoriented
- HH 4 WFNS 3
- HH 4 WFNS 4
- HH 5 WFNS 5
- HH 3 WFNS 2
What fisher grading has a localized clot or vertical layer more than 1 mm thick?
GRADE 3
Grade 1 no subarachnoid (SAH) or intraventricular haemorrhage (IVH) detected incidence of symptomatic vasospasm: 21%
Grade 2 diffuse thin (<1 mm) SAHno clots incidence of symptomatic vasospasm: 25%
Grade 3 localised clots and/or layers of blood >1 mm in thickness no IV Hincidence of symptomatic vasospasm: 37%
Grade 4 diffuse or no SAH/ICH or IVH present incidence of symptomatic vasospasm: 31%
What is the lifetime risk of ICH in a 30 year old patient with AVM?
75%
105- patient’s age
What is the spletzer martin grade for an AVM: 4cmin the hypothalamuswith deep drainage
2+1+1=4
size of nidussmall (<3 cm) = 1medium (3-6 cm) = 2large (>6 cm) = 3
eloquence of adjacent brain non-eloquent = 0 eloquent = 1
venous drainage superficial veins only = 0 deep veins = 1
What are the 3 components of the Oxfordshire Stroke classification that needs to be fulfilled to make a diagnosis of Total Anterior Circulation?
- Unilateral motor or sensory deficit2. Higher cortical dysfunction3. Homonymous hemianopia
How many features need to be fulfilled for an PAC oxfordshire classification to be made?
2 of the ff:1. Unilateral motor or sensory deficit2. Higher cortical dysfunction3. Homonymous hemianopia3 for TAC
According to the INTERSTROKE STUDY what are the top 2 risk factors associated with Stroke?
Hypertension and regular physical ativity
According to the RIFASAF Study what are the top 2 risk factors associated with Stroke?
Hypertension and MI
What is the absolute LDL-C value for treatment with statins for primary prevention?
more than or equal to 190mg per dl
Treatment with warfarin for 3 months is indicated for patients with Stroke or TIA in the setting of anterior wall STEMI if _______ is seen on 2d echo?
Anterior wall apical akinesis or dyskinesis
What are the valvular heart diseases that merit anticoagulation?
Prosthetic heart valves and rhematic mitral valve disease
How does treatment with anticoagulation vary for patients with a prosthetic aortic heart valve and mitral valve differ?
Higher target for mitral INR 2.5 to 3.5 while 2.0-3.0 for aortic
What factors favor the performance of CEA in patients with carotid artery stenosis of 50-69%?
Male sex, hemispheric symptoms, treatment within 2 weeks of non-disabling stroke of tia
What is considered a high risk CHADSVASC2 score? How about a high risk HASBLED score?
> =2
>=3
Which drugs are being studies by the ff:
- RELY AF
- ARISTOTLE
- ROCKET-AF
- RELY AF: Dabigatran2. ARISTOTLE: Apixaban3. ROCKET-AF: Rivaroxaban
Which NOAC’s are:
- Superior to warfarin for Stroke and Systemic Embolism
- Superior to warfarin for ischemic stroke
- All cause mortality
- Major bleeding
- Superior to warfarin for Stroke and Systemic Embolism: Dabigatran 150 and Apixaban
- Superior to warfarin for ischemic stroke: Dabigatran 150
- All cause mortality: Apixaban
- Major bleeding: Dabigatran 110 and apixaban
For non-valvular AF what score requires the use of NOACs/ anticoagulation?
More than or equal to 1 as long as one is NOT female gender
What is the threshold creatinine clearance for patients on NOACs?
<30ml/min– all three NOACs are NOT recommended
What is the minimum decrease in BP that is associated with benefit in hypertensive?
10/5mmHg